Immune activation, allergic drug toxicity and mortality in HIV-positive tuberculosis (Q38888111)

7 September 2017

Immune activation, allergic drug toxicity and mortality in HIV-positive tuberculosis (English)

1 reference

ORCID Public Data File 2021

7 September 2017

1 reference

1 reference

author name string

Wallis RS

1

1 reference

7 September 2017

Helfand MS

2

1 reference

7 September 2017

Whalen CC

3

1 reference

7 September 2017

Johnson JL

4

1 reference

7 September 2017

Mugerwa RD

5

1 reference

7 September 2017

Vjecha M

6

1 reference

7 September 2017

Okwera A

7

1 reference

7 September 2017

Ellner JJ

8

1 reference

7 September 2017

1 December 1996

1 reference

Tubercle and lung disease

7 September 2017

1 reference

7 September 2017

77

1 reference

7 September 2017

6

1 reference

7 September 2017

516-523

1 reference

Influence of tuberculosis on human immunodeficiency virus (HIV-1): enhanced cytokine expression and elevated beta 2-microglobulin in HIV-1-associated tuberculosis

7 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990049-0

7 January 2021

The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990049-0

7 January 2021

Induction of NF-kappa B during monocyte differentiation is associated with activation of HIV-gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990049-0

7 January 2021

Randomised trial of thiacetazone and rifampicin-containing regimens for pulmonary tuberculosis in HIV-infected Ugandans. The Makerere University-Case Western University Research Collaboration

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990049-0

7 January 2021

Relationship of the manifestations of tuberculosis to CD4 cell counts in patients with human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990049-0

7 January 2021

Production of tumor necrosis factor alpha by monocytes from patients with pulmonary tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990049-0

7 January 2021

Infusion of tumor necrosis factor (TNF) causes an increase in circulating TNF-binding protein in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990049-0

7 January 2021

Soluble receptors for tumor necrosis factor as predictors of progression to AIDS in asymptomatic human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990049-0

7 January 2021

Biosynthesis and metabolism of pterins in peripheral blood mononuclear cells and leukemia lines of man and mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990049-0

7 January 2021

The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990049-0

7 January 2021

Early markers of HIV infection and subclinical disease progression.

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990049-0

7 January 2021

Evaluation of hiv p24 antigen, beta2-microglobulin, neopterin, soluble cd4, soluble cd8, and soluble interleukin-2 receptor levels in patients with aids or aids-related complex treated with 2′,3′-dideoxyinosine (ddl)

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990049-0

7 January 2021

Accelerated course of human immunodeficiency virus infection after tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990049-0

7 January 2021

Quantitative bacillary response to treatment in HIV-associated pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990049-0

7 January 2021

Cohort study of HIV-positive and HIV-negative tuberculosis, Nairobi, Kenya: comparison of bacteriological results

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990049-0

7 January 2021

Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990049-0

7 January 2021

Cutaneous hypersensitivity reactions due to thiacetazone in HIV-1 seropositive patients treated for tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990049-0

7 January 2021

Increased mortality and tuberculosis treatment failure rate among human immunodeficiency virus (HIV) seropositive compared with HIV seronegative patients with pulmonary tuberculosis treated with "standard" chemotherapy in Kinshasa, Zaire

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990049-0

7 January 2021

Absence of bacteremia with Mycobacterium avium-intracellulare in Ugandan patients with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990049-0

7 January 2021

The early bactericidal activity of rifabutin measured by sputum viable counts in Hong Kong patients with pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0962-8479%2896%2990049-0

7 January 2021

10.1016/S0962-8479(96)90049-0

Identifiers

DOI

1 reference

7 September 2017

1 reference